These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14551292)

  • 61. Molecular subtypes of colorectal cancer: An emerging therapeutic opportunity for personalized medicine.
    Singh MP; Rai S; Pandey A; Singh NK; Srivastava S
    Genes Dis; 2021 Mar; 8(2):133-145. PubMed ID: 33997160
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RAS, Cellular Plasticity, and Tumor Budding in Colorectal Cancer.
    Maffeis V; Nicolè L; Cappellesso R
    Front Oncol; 2019; 9():1255. PubMed ID: 31803624
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Novel Prognostic DNA Methylation Panel for Colorectal Cancer.
    Chung HH; Kuo CC; Hsiao CW; Chen CY; Hu JM; Hsu CH; Chou YC; Lin YW; Shih YL
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547144
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Molecular Hallmarks of the Serrated Pathway in Colorectal Cancer.
    De Palma FDE; D'Argenio V; Pol J; Kroemer G; Maiuri MC; Salvatore F
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31330830
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PBX3 hypermethylation in peripheral blood leukocytes predicts better prognosis in colorectal cancer: A propensity score analysis.
    Sun H; Huang H; Li D; Zhang L; Zhang Y; Xu J; Liu Y; Liu Y; Zhao Y
    Cancer Med; 2019 Jul; 8(8):4001-4011. PubMed ID: 31140752
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Biomarker-driven and molecular targeted therapies for colorectal cancers.
    Schirripa M; Cohen SA; Battaglin F; Lenz HJ
    Semin Oncol; 2018 Jun; 45(3):124-132. PubMed ID: 30262397
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Molecular subtyping of colorectal cancer: Recent progress, new challenges and emerging opportunities.
    Wang W; Kandimalla R; Huang H; Zhu L; Li Y; Gao F; Goel A; Wang X
    Semin Cancer Biol; 2019 Apr; 55():37-52. PubMed ID: 29775690
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.
    Vedeld HM; Goel A; Lind GE
    Semin Cancer Biol; 2018 Aug; 51():36-49. PubMed ID: 29253542
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical and prognosis value of the CIMP status combined with MLH1 or p16
    Saadallah-Kallel A; Abdelmaksoud-Dammak R; Triki M; Charfi S; Khabir A; Sallemi-Boudawara T; Mokdad-Gargouri R
    Med Oncol; 2017 Aug; 34(8):147. PubMed ID: 28730335
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Molecular Biomarkers of Colorectal Cancer and Cancer Disparities: Current Status and Perspective.
    Manne U; Jadhav T; Putcha BK; Samuel T; Soni S; Shanmugam C; Suswam EA
    Curr Colorectal Cancer Rep; 2016 Dec; 12(6):332-344. PubMed ID: 28626361
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Vedeld HM; Merok M; Jeanmougin M; Danielsen SA; Honne H; Presthus GK; Svindland A; Sjo OH; Hektoen M; Eknaes M; Nesbakken A; Lothe RA; Lind GE
    Int J Cancer; 2017 Sep; 141(5):967-976. PubMed ID: 28542846
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer.
    Kandimalla R; Linnekamp JF; van Hooff S; Castells A; Llor X; Andreu M; Jover R; Goel A; Medema JP
    Oncogenesis; 2017 Apr; 6(4):e308. PubMed ID: 28368388
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CpG Island Methylator Phenotype-High Colorectal Cancers and Their Prognostic Implications and Relationships with the Serrated Neoplasia Pathway.
    Rhee YY; Kim KJ; Kang GH
    Gut Liver; 2017 Jan; 11(1):38-46. PubMed ID: 27885175
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma.
    Srdjan M; Jadranka A; Ivan D; Branimir Z; Daniela B; Petar S; Velimir M; Zoran K
    Indian J Med Res; 2016 May; 143(Supplement):S104-S111. PubMed ID: 27748284
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase I/II study of azacitidine and capecitabine/oxaliplatin (CAPOX) in refractory CIMP-high metastatic colorectal cancer: evaluation of circulating methylated vimentin.
    Overman MJ; Morris V; Moinova H; Manyam G; Ensor J; Lee MS; Eng C; Kee B; Fogelman D; Shroff RT; LaFramboise T; Mazard T; Feng T; Hamilton S; Broom B; Lutterbaugh J; Issa JP; Markowitz SD; Kopetz S
    Oncotarget; 2016 Oct; 7(41):67495-67506. PubMed ID: 27542211
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Important molecular genetic markers of colorectal cancer.
    Kudryavtseva AV; Lipatova AV; Zaretsky AR; Moskalev AA; Fedorova MS; Rasskazova AS; Shibukhova GA; Snezhkina AV; Kaprin AD; Alekseev BY; Dmitriev AA; Krasnov GS
    Oncotarget; 2016 Aug; 7(33):53959-53983. PubMed ID: 27276710
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Impact of Mismatch Repair Status in Colorectal Cancer on the Decision to Treat With Adjuvant Chemotherapy: An Australian Population-Based Multicenter Study.
    He EY; Hawkins NJ; Mak G; Roncolato F; Goldstein D; Liauw W; Clingan P; Chin M; Ward RL
    Oncologist; 2016 May; 21(5):618-25. PubMed ID: 27009937
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Different definitions of CpG island methylator phenotype and outcomes of colorectal cancer: a systematic review.
    Jia M; Gao X; Zhang Y; Hoffmeister M; Brenner H
    Clin Epigenetics; 2016; 8():25. PubMed ID: 26941852
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Wild-type APC predicts poor prognosis in microsatellite-stable proximal colon cancer.
    Jorissen RN; Christie M; Mouradov D; Sakthianandeswaren A; Li S; Love C; Xu ZZ; Molloy PL; Jones IT; McLaughlin S; Ward RL; Hawkins NJ; Ruszkiewicz AR; Moore J; Burgess AW; Busam D; Zhao Q; Strausberg RL; Lipton L; Desai J; Gibbs P; Sieber OM
    Br J Cancer; 2015 Sep; 113(6):979-88. PubMed ID: 26305864
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Epigenetic Alterations in Colorectal Cancer: Emerging Biomarkers.
    Okugawa Y; Grady WM; Goel A
    Gastroenterology; 2015 Oct; 149(5):1204-1225.e12. PubMed ID: 26216839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.